CHET MYER: Open Payments
NPI 1245883446 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 21 payments from 7 companies in 2025. Trend: 2023 $544 · 2024 $658 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $165 |
| GENZYME CORPORATION | 3 | $65 |
| ABBVIE INC. | 2 | $37 |
| Lundbeck LLC | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Optinose US, Inc. | 1 | $21 |
Products named: NUCALA, DUPIXENT, VYEPTI, AIRSUPRA, UBRELVY, Xhance, QULIPTA.
Industry payments across LA — which companies pay providers there.
